Home > Annual Financials > INNOVA CAPTAB

INNOVA CAPTAB Financial Statement Analysis
[BOM: 544067|NSE : INNOVACAP]

The Revenues of INNOVA CAPTAB have increased by 15.72% YoY .
The Earnings Per Share (EPS) of INNOVA CAPTAB has decreased by -97.34 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

INNOVA CAPTAB Last 5 Annual Financial Results
[BOM: 544067|NSE : INNOVACAP]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹926 Cr₹801 Cr₹411 Cr₹373 Cr₹356 Cr
Expenses ₹813 Cr₹705 Cr₹356 Cr₹322 Cr₹315 Cr
Operating Profit (Excl OI) ₹114 Cr₹96 Cr₹54 Cr₹51 Cr₹41 Cr
Other Income ₹9.20 Cr₹2.88 Cr₹1.37 Cr₹1.30 Cr₹0.22 Cr
Interest ₹20 Cr₹5.68 Cr₹3.93 Cr₹4.63 Cr₹5.58 Cr
Depreciation ₹11 Cr₹7.50 Cr₹5.59 Cr₹10 Cr₹11 Cr
Profit Before Tax ₹92 Cr₹86 Cr₹46 Cr₹38 Cr₹25 Cr
Profit After Tax ₹68 Cr₹64 Cr₹35 Cr₹28 Cr₹20 Cr
Consolidated Net Profit ₹68 Cr₹64 Cr₹34 Cr₹28 Cr₹20 Cr
Earnings Per Share (Rs)₹14.15₹531.54₹286.86₹232.23₹166.01
PAT Margin (%)7.217.918.387.465.58
ROE(%)28.0236.1927.0428.9224.10
ROCE(%)24.3430.6428.4226.4819.63
Total Debt/Equity(x)0.850.950.310.480.87

Key Financials

Market Cap : ₹ 2,688.1 Cr
Revenue (TTM) : ₹ 1,069.6 Cr
Net Profit(TTM) : ₹ 86.4 Cr
EPS (TTM) : ₹ 15.1
P/E (TTM) : 31.1

Industry Peers & Returns1W1M1Y
INNOVA CAPTAB 2% 0.1% NA
SUN PHARMACEUTICAL INDUSTRIES 1.6% -3.7% 60%
CIPLA -2% -4.6% 49.9%
DR REDDYS LABORATORIES -3.1% -4.7% 21.6%
ZYDUS LIFESCIENCES -2.1% -0.9% 89.1%
DIVIS LABORATORIES -0.9% 4.2% 14.3%
MANKIND PHARMA 3.1% -5.1% 57.7%
TORRENT PHARMACEUTICALS 1.6% 2% 56.5%
LUPIN 1.3% 1.9% 125.1%


INNOVA CAPTAB Revenues
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

15.72 %

5 Yr CAGR

27.03 %

Years Revenues % Change
Mar2023 ₹926 Cr
15.72
Mar2022 ₹801 Cr
94.94
Mar2021 ₹411 Cr
10.00
Mar2020 ₹373 Cr
4.92
Mar2019 ₹356 Cr -


INNOVA CAPTAB Operating Profit
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

18.36 %

5 Yr CAGR

29.20 %

Years Operating Profit % Change
Mar2023 ₹114 Cr
18.36
Mar2022 ₹96 Cr
76.23
Mar2021 ₹54 Cr
6.98
Mar2020 ₹51 Cr
24.88
Mar2019 ₹41 Cr -

Operating Margins
Y-o-Y

2.34 %

5 Yr CAGR

1.72 %

Years Operating Margin% % Change
Mar2023 12.27%
2.34
Mar2022 11.99%
-9.65
Mar2021 13.27%
-2.71
Mar2020 13.64%
19.02
Mar2019 11.46% -

INNOVA CAPTAB Profit After Tax
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

6.45 %

5 Yr CAGR

35.88 %

Years Profit After Tax % Change
Mar2023 ₹68 Cr
6.45
Mar2022 ₹64 Cr
85.30
Mar2021 ₹34 Cr
23.53
Mar2020 ₹28 Cr
39.89
Mar2019 ₹20 Cr -

PAT Margins
Y-o-Y

-8.85 %

5 Yr CAGR

6.62 %

Years PAT Margin(%) % Change
Mar2023 7.21 %
-8.85
Mar2022 7.91 %
-5.61
Mar2021 8.38 %
12.33
Mar2020 7.46 %
33.69
Mar2019 5.58 % -

INNOVA CAPTAB Earnings Per Share (EPS)
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

-97.34 %

5 Yr CAGR

-45.97 %

Years EPS % Change
Mar2023 ₹14
-97.34
Mar2022 ₹532
85.30
Mar2021 ₹287
23.52
Mar2020 ₹232
39.89
Mar2019 ₹166 -

INNOVA CAPTAB Return on Capital Employed (ROCE)
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

-20.56 %

5 Yr CAGR

5.52 %

Years ROCE % Change
Mar2023 24.34%
-20.56
Mar2022 30.64%
7.81
Mar2021 28.42%
7.33
Mar2020 26.48%
34.90
Mar2019 19.63% -

INNOVA CAPTAB Share Price vs Sensex

Current Share Price : ₹470.0
Current MarketCap: ₹ 2,688.1 Cr
Updated EOD on :May 14,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
INNOVA CAPTAB

2%

0.1%

NA
SENSEX

-0.6%

-2.1%

18.4%

INNOVA CAPTAB related INDICES

BSE Indices1W1M1Y
S&P BSE IPO 0.9% 1% 70.4%
S&P BSE MIDSMALLCAP 0.7% 1.3% 58.2%
S&P BSE SMALL CAP 0.4% 0.4% 57.1%
S&P BSE ALLCAP 0.3% -0.5% 35%
S&P BSE HEALTHCARE -0% -1.8% 50.6%
No NSE index found

You may also like the below Video Courses


FAQ about INNOVA CAPTAB Financials


How the annual revenues of INNOVA CAPTAB have changed ?

The Revenues of INNOVA CAPTAB have increased by 15.72% YoY .

How the Earnings per Share (EPS) of INNOVA CAPTAB have changed?

The Earnings Per Share (EPS) of INNOVA CAPTAB has decreased by -97.34 % YoY .